This inventor holds 3 USPTO granted patents. Top assignees: Bayer Corporation, Chiron Diagnostics Corporation. Active years: 1998-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2003
Title: Eve H Barlow: Innovator in Immunoassay Techniques
Introduction
Eve H Barlow is a prominent inventor based in Holliston, MA (US). She has made significant contributions to the field of immunoassays, particularly through her innovative use of anti-allotypic monoclonal antibodies. With a total of 3 patents to her name, Barlow's work has enhanced the accuracy and specificity of immunoassay techniques.
Latest Patents
One of her latest patents focuses on improved immunoassay techniques for detecting the presence of analytes in liquid samples. The methods utilize anti-allotypic monoclonal antibodies as capture reagents for primary binding proteins specific to the analytes of interest. These monoclonal antibodies exhibit high specificity for the allotypic determinants present on the primary binding protein. By employing anti-allotypic monoclonal antibodies as capture reagents, the immunoassay's specificity and accuracy are significantly enhanced, as interference from endogenous immunoglobulins in the sample is notably reduced. This invention also includes the provision of anti-allotypic monoclonal antibodies.
Career Highlights
Throughout her career, Eve H Barlow has worked with notable companies such as Bayer Corporation and Chiron Diagnostics Corporation. Her experience in these organizations has contributed to her expertise in the field of immunoassays and biotechnology.
Collaborations
Barlow has collaborated with several professionals in her field, including Eddie Carroll, III and John T Unger. These collaborations have likely enriched her research and development efforts.
Conclusion
Eve H Barlow is a distinguished inventor whose work in immunoassay techniques has made a significant impact in the field. Her innovative approaches continue to advance the accuracy and specificity of diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
